These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1800944)

  • 1. Analog of neuropeptide FF attenuates morphine abstinence syndrome.
    Malin DH; Lake JR; Leyva JE; Hammond MV; Rogillio RB; Arcangeli KR; Ludgate K; Moore GM; Payza K
    Peptides; 1991; 12(5):1011-4. PubMed ID: 1800944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analog of neuropeptide FF attenuates morphine tolerance.
    Lake JR; Hebert KM; Payza K; Deshotel KD; Hausam DD; Witherspoon WE; Arcangeli KA; Malin DH
    Neurosci Lett; 1992 Nov; 146(2):203-6. PubMed ID: 1491790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome.
    Malin DH; Lake JR; Smith DA; Jones JA; Morel J; Claunch AE; Stevens PA; Payza K; Ho KK; Liu J
    Drug Alcohol Depend; 1995 Nov; 40(1):37-42. PubMed ID: 8746922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FF.
    Malin DH; Lake JR; Jones JA; Morel J; Moon WD; Corbit BP; Smith DA; Claunch AE; Kacher D; Stevens PA; Webb SL
    Peptides; 1996; 17(4):615-8. PubMed ID: 8804070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FMRF-NH2-like mammalian octapeptide: possible role in opiate dependence and abstinence.
    Malin DH; Lake JR; Hammond MV; Fowler DE; Rogillio RB; Brown SL; Sims JL; Leecraft BM; Yang HY
    Peptides; 1990; 11(5):969-72. PubMed ID: 2284204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome.
    Malin DH; Lake JR; Arcangeli KR; Deshotel KD; Hausam DD; Witherspoon WE; Carter VA; Yang HY; Pal B; Burgess K
    Life Sci; 1993; 53(17):PL261-6. PubMed ID: 8412495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of neuropeptide FF neurons in the brainstem nucleus tractus solitarius following cardiovascular challenge and opiate withdrawal.
    Jhamandas JH; Harris KH; Petrov T; Yang HY; Jhamandas KH
    J Comp Neurol; 1998 Dec; 402(2):210-21. PubMed ID: 9845244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain.
    Rothman RB; Brady LS; Xu H; Long JB
    Peptides; 1993; 14(6):1271-7. PubMed ID: 8134310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in the effects of neuropeptide FF and IgG from neuropeptide FF on morphine- and stress-induced analgesia.
    Kavaliers M; Innes D
    Peptides; 1992; 13(3):603-7. PubMed ID: 1523172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus.
    Hong M; Milne B; Jhamandas K
    Brain Res; 1993 Sep; 623(1):131-41. PubMed ID: 8221081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF.
    Malin DH; Lake JR; Short PE; Blossman JB; Lawless BA; Schopen CK; Sailer EE; Burgess K; Wilson OB
    Pharmacol Biochem Behav; 1996 Jul; 54(3):581-5. PubMed ID: 8743632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats.
    Maldonado R; Girdlestone D; Roques BP
    Neurosci Lett; 1993 Jun; 156(1-2):135-40. PubMed ID: 7692360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat.
    Lake JR; Hammond MV; Shaddox RC; Hunsicker LM; Yang HY; Malin DH
    Neurosci Lett; 1991 Oct; 132(1):29-32. PubMed ID: 1787914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of naloxone-precipitated morphine withdrawal syndromes in rats by neuropeptide FF analogs.
    Tan PP; Chen JC; Li JY; Liang KW; Wong CH; Huang EY
    Peptides; 1999; 20(10):1211-7. PubMed ID: 10573293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms.
    Haffmans J; Dzoljic MR
    Gen Pharmacol; 1987; 18(1):103-5. PubMed ID: 3549428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide FF reduces food intake in rats.
    Murase T; Arima H; Kondo K; Oiso Y
    Peptides; 1996; 17(2):353-4. PubMed ID: 8801545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intraventricular infusion model for inducing morphine dependence in rats: quantitative assessment of precipitated withdrawal.
    Huffman RD; Simmons KE; Lum JT
    Behav Neurosci; 1985 Oct; 99(5):861-80. PubMed ID: 3843305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
    Lee PH; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment.
    Stinus L; Allard M; Gold L; Simonnet G
    Peptides; 1995; 16(7):1235-41. PubMed ID: 8545244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.